Search research articles
Contact Us
Filters
Showing results (61-70 of 135) with videos related to
Page
of 14
Sort By:
Journal of Health Economics and Outcomes Research
|
September 4, 2023
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
Carlos Rubio-Terrés, Ruth Graefenhain de Codes, Darío Rubio-Rodríguez, et al.
International Journal of Environmental Research and Public Health
|
May 17, 2019
Analysis of Required Investigations of Work-Related Musculoskeletal Disorders in Spain
Jesús Antonio Carrillo-Castrillo, Ventura Pérez-Mira, María Del Carmen Pardo-Ferreira, et al.
Safety Science
|
May 15, 2020
Disposable masks: Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemic
Juan Carlos Rubio-Romero, María Del Carmen Pardo-Ferreira, Juan Antonio Torrecilla-García, et al.
Expert Review of Cardiovascular Therapy
|
February 7, 2025
Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)
Manuel Anguita, Francisco Marín, Javier Soto, et al.
Atencion Primaria
|
October 6, 2006
[Study of flu costs]
Xavier Badia Llach, Montserrat Roset Gamisans, José M Francés Tudel, et al.
Resuscitation
|
June 11, 2023
Influence of donor capnometry on renal graft evolution in uncontrolled donation after circulatory death
Carlos Rubio-Chacón, Alonso Mateos-Rodríguez, Fernando Neria-Serrano, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 9, 2026
Cost of rimegepant and lasmiditan associated adverse events, for acute treatment in migraine in Spain
Sonia Santos-Lasaosa, Beatriz Armada, Carlota Moya-Alarcón, et al.
Gastroenterologia Y Hepatologia
|
June 21, 2020
Economic impact of health resource optimisation in the approach to patients with hepatitis C
Juan Turnes, Federico García, Moisés Diago, et al.
Frontiers in Pharmacology
|
March 17, 2025
Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review
Carolina Garcia Vidal, Jonathan González, Carlos Lumbreras, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2002
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
Patrik Andersson, Jacqueline McGuire, Carlos Rubio, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 135) with videos related to
Sort By:
Page
of 14
Journal of Health Economics and Outcomes Research
|
September 4, 2023
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
Carlos Rubio-Terrés, Ruth Graefenhain de Codes, Darío Rubio-Rodríguez, et al.
International Journal of Environmental Research and Public Health
|
May 17, 2019
Analysis of Required Investigations of Work-Related Musculoskeletal Disorders in Spain
Jesús Antonio Carrillo-Castrillo, Ventura Pérez-Mira, María Del Carmen Pardo-Ferreira, et al.
Safety Science
|
May 15, 2020
Disposable masks: Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemic
Juan Carlos Rubio-Romero, María Del Carmen Pardo-Ferreira, Juan Antonio Torrecilla-García, et al.
Expert Review of Cardiovascular Therapy
|
February 7, 2025
Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)
Manuel Anguita, Francisco Marín, Javier Soto, et al.
Atencion Primaria
|
October 6, 2006
[Study of flu costs]
Xavier Badia Llach, Montserrat Roset Gamisans, José M Francés Tudel, et al.
Resuscitation
|
June 11, 2023
Influence of donor capnometry on renal graft evolution in uncontrolled donation after circulatory death
Carlos Rubio-Chacón, Alonso Mateos-Rodríguez, Fernando Neria-Serrano, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 9, 2026
Cost of rimegepant and lasmiditan associated adverse events, for acute treatment in migraine in Spain
Sonia Santos-Lasaosa, Beatriz Armada, Carlota Moya-Alarcón, et al.
Gastroenterologia Y Hepatologia
|
June 21, 2020
Economic impact of health resource optimisation in the approach to patients with hepatitis C
Juan Turnes, Federico García, Moisés Diago, et al.
Frontiers in Pharmacology
|
March 17, 2025
Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review
Carolina Garcia Vidal, Jonathan González, Carlos Lumbreras, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2002
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
Patrik Andersson, Jacqueline McGuire, Carlos Rubio, et al.
Page
of 14